Related references
Note: Only part of the references are listed.Old medications and new targeted therapies in systemic sclerosis
Vivek Nagaraja et al.
RHEUMATOLOGY (2015)
Correlates and Responsiveness to Change of Measures of Skin and Musculoskeletal Disease in Early Diffuse Systemic Sclerosis
Alexandra B. Wiese et al.
ARTHRITIS CARE & RESEARCH (2014)
Definitions and Diagnosis of Pulmonary Hypertension
Marius M. Hoeper et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Patterns and predictors of change in outcome measures in clinical trials in scleroderma: An individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis
P. A. Merkel et al.
ARTHRITIS AND RHEUMATISM (2012)
The Systemic Lupus Erythematosus Responder Index (SRI); A new SLE disease activity assessment
K. M. A. C. Luijten et al.
AUTOIMMUNITY REVIEWS (2012)
Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies
Muriel Elhai et al.
RHEUMATOLOGY (2012)
Concepts of functioning and health important to people with systemic sclerosis: a qualitative study in four European countries
Tanja A. Stamm et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey
Marielle Bassel et al.
RHEUMATOLOGY (2011)
Methods of Formal Consensus in Classification/Diagnostic Criteria and Guideline Development
Raj Nair et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort? Results from the Canadian Scleroderma Research Group (CSRG)
Xiangning Fan et al.
RHEUMATOLOGY INTERNATIONAL (2010)
Course of the Modified Rodnan Skin Thickness Score in Systemic Sclerosis Clinical Trials Analysis of Three Large Multicenter, Double-Blind, Randomized Controlled Trials
Sogol Amjadi et al.
ARTHRITIS AND RHEUMATISM (2009)
Recombinant Human Relaxin in the Treatment of Systemic Sclerosis With Diffuse Cutaneous Involvement A Randomized, Double-Blind, Placebo-Controlled Trial
Dinesh Khanna et al.
ARTHRITIS AND RHEUMATISM (2009)
Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
Dinesh Khanna et al.
JOURNAL OF RHEUMATOLOGY (2009)
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial
Peter A. Merkel et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Development of a provisional core set of response measures for clinical trials of systemic sclerosis
D. Khanna et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
A severity scoring tool to assess the neurological features of neuronopathic Gaucher disease
E. H. Davies et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Strictly proper scoring rules, prediction, and estimation
Tilmann Gneiting et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2007)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Scleroderma: from cell and molecular mechanisms to disease models
DJ Abraham et al.
TRENDS IN IMMUNOLOGY (2005)
Mortality in systemic sclerosis: an international meta-analysis of individual patient data
JPA Ioannidis et al.
AMERICAN JOURNAL OF MEDICINE (2005)
European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score
G Valentini et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon
PA Merkel et al.
ARTHRITIS AND RHEUMATISM (2002)
Share Paper
